Ticker: TMO | Published: 2026-09-23
TMO climbs on product news
Thermo Fisher is rallying moderately as news of its new Gibco cell culture media panel and a multi-omics data platform launch with Mayo Clinic lifts sentiment, aided by a strong tape in healthcare and tech.
Sources: https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-launches-gibco-123000578.html, https://www.digitalhealthnews.com/mayo-cl